共 18 条
[1]
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study[J] Javier Fernández;Juan Acevedo;Miriam Castro;Orlando Garcia;Carlos Rodríguez de Lope;Daria Roca;Marco Pavesi;Elsa Sola;Leticia Moreira;Anibal Silva;Tiago Seva‐Pereira;Francesco Corradi;Jose Mensa;Pere Ginès;Vicente Arroyo Hepatology 2012,
[2]
Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis[J] Elizabeth Verna;Robert Brown;Erica Farrand;Elsa Pichardo;Catherine Forster;David Sola-Del Valle;Sarah Adkins;Meghan Sise;Juan Oliver;Jai Radhakrishnan;Jonathan Barasch;Thomas Nickolas Digestive Diseases and Sciences 2012,
[3]
Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study[J] Virendra Singh;Sahdeb P. Dhungana;Baljinder Singh;Rajesh Vijayverghia;Chander K. Nain;Navneet Sharma;Ashish Bhalla;Pramod K. Gupta Journal of Hepatology 2011,
[4]
Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo[J] Pankaj Tyagi;Praveen Sharma;Barjesh Chander Sharma;Amarender Singh Puri;Ashish Kumar;Shiv Kumar Sarin European Journal of Gastroenterology & Hepatology 2011,
[5]
A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method[J] Michel Henry Mendler;Arun Agarwal;Mateen Trimzi;Erika Madrigal;Matthew Tsushima;Elliot Joo;Marisela Santiago;Elissa Flores;Gabriel David;Adrienne Workman;Bruce Runyon Journal of Hepatology 2010,
[6]
Usefulness of Serum N-terminal–ProBNP in Distinguishing Ascites Due to Cirrhosis From Ascites Due to Heart Failure[J] Todd A. Sheer;Elliot Joo;Bruce A. Runyon Journal of Clinical Gastroenterology 2010,
[7]
Outcomes of patients with chest tube insertion for hepatic hydrothorax[J] Eric S. Orman;Anna S. F. Lok Hepatology International 2009,
[8]
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised; double-blind controlled study[J] Giovanni Addolorato;Lorenzo Leggio;Anna Ferrulli;Silvia Cardone;Luisa Vonghia;Antonio Mirijello;Ludovico Abenavoli;Cristina D'Angelo;Fabio Caputo;Antonella Zambon;Paul S Haber;Giovanni Gasbarrini The Lancet 2007,
[9]
Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage[J] Javier Fernández;Luis Ruiz del Arbol;Cristina Gómez;Rosa Durandez;Regina Serradilla;Carlos Guarner;Ramón Planas;Vicente Arroyo;Miguel Navasa Gastroenterology 2006,
[10]
Choosing the location for non‐image guided abdominal paracentesis[J] HidekiSakai;Todd A.Sheer;Michel H.Mendler;Bruce A.Runyon Liver International 2005,